Thursday, December 13, 2018 11:48:23 PM
Exas chart above
Wow lot's of negativity and impatience out here.
I think AMRN may follow a similar path to EXAS. Exas got USPSTF approval for it's cologuard product in July 2016, then dropped after a big pop, then went sideways for about 6-9 months before starting it's upward climb. Both Cologuard and V are game changing products that took time for physician and insurance acceptance before taking off. I see alot of similarities between the products, the market and the insurance and provider issues.
We'll see, but I think patience will pay off in a big way with a similar chart.
Recent AMRN News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
